- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06402682
Management of Esophageal Atresia With Right Aortic Arch: Is the Side of Approach Important?
May 21, 2024 updated by: Fondation Lenval
Esophageal atresia is associated with a right aortic arch in 2 to 13% of cases.
Despite previous studies, consensus on the optimal surgical approach remains lacking.
This study aims to analyze the management of esophageal atresia with a right aortic arch in France over three decades, to define the most effective surgical strategy and identify associated complications.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
19
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jourisse Meye, MD
- Phone Number: +33767332556
- Email: meye.j@chu-nice.fr
Study Contact Backup
- Name: Jean-François Lecompte, MD
- Email: jean-francois.lecompte@hpu.lenval.com
Study Locations
-
-
-
Nice, France, 06200
- Recruiting
- Fondation Lenval
-
Contact:
- Jourisse Meye, MD
- Phone Number: +33767332556
- Email: meye.j@chu-nice.fr
-
Contact:
- Jean-François Lecompte, MD
- Email: jean-francois.lecompte@hpu.lenval.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All patients born with esophageal atresia and right aortic arch between 1990 et 2022
Description
Inclusion Criteria:
- Having been operated on for esophageal atresia and right aortic arch
Exclusion Criteria:
- NO
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Right approach
|
Right approach of the management of esophageal atresia with a right aortic arch
|
|
Left approach
|
Left approach of the management of esophageal atresia with a right aortic arch
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative complications
Time Frame: During the first 40 post-operative days
|
Post-operative complications after Esophageal atresia repair
|
During the first 40 post-operative days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
specific complications
Time Frame: During the first 40 post-operative days
|
Specific complications related to esophageal atresia and right aortic arch repair.
The secondary outcome assessment was based on the declaration of clinical post-operative complications on patients medical file"
|
During the first 40 post-operative days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
May 3, 2024
First Submitted That Met QC Criteria
May 3, 2024
First Posted (Actual)
May 7, 2024
Study Record Updates
Last Update Posted (Actual)
May 22, 2024
Last Update Submitted That Met QC Criteria
May 21, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-HPNCL-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Right Aortic Arch
-
University Hospital, MontpellierHospices Civils de Lyon; University Hospital, Rouen; Centre Hospitalier Universitaire... and other collaboratorsCompletedIsolated Right Aortic ArchFrance
-
University Hospital MuensterRecruitingAortic Arch Aneurysm | Aortic Arch | Dissection of Aortic Arch | Triple BranchGermany
-
Changhai HospitalXiangya Hospital of Central South University; West China Hospital; First Affiliated... and other collaboratorsNot yet recruitingAortic Arch Aneurysm | Aortic Arch Pseudoaneurysm | Aortic Arch UlcerChina
-
W.L.Gore & AssociatesRecruitingAortic Arch Aneurysm | Aortic Arch DissectionUnited States
-
Emory UniversityCompletedAortic Arch Replacement | Hemi Arch ReplacementUnited States
-
Fuji Systems CorporationAvaniaActive, not recruitingAortic Aneurysm | Aortic Dissection | Aortic Arch Aneurysm | Aortic Arch; Aneurysm, DissectingGermany, Netherlands
-
Shanghai MicroPort Endovascular MedTech(Group)Co...Not yet recruitingAortic Arch DiseaseChina
-
Ospedale San DonatoRecruitingAortic Diseases | Aortic Arch | Bovine ArchItaly
-
Hangzhou Endonom Medtech Co., Ltd.Recruiting
-
Hangzhou Endonom Medtech Co., Ltd.Active, not recruiting
Clinical Trials on Right approach
-
Capital Medical UniversityCompletedTransradial Approach, Primary PCI, ST-segment Elevation Myocardial InfarctionChina
-
Capital Medical UniversityCompletedPercutaneous Coronary | Transradial Approach, | Coronary Angiography,China
-
Ospedale Sandro Pertini, RomaCompleted
-
Fudan UniversityCompleted
-
NYU Langone HealthCompletedCoronary Artery DiseaseUnited States
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknown
-
Sohag UniversityNot yet recruitingMinimally Invasive Mitral Valve SurgeryEgypt
-
Alexandria UniversityCompletedInfraclavicular Vein Cannulation | Venous CannulationEgypt
-
Sohag UniversityCompletedCentral Line ComplicationEgypt
-
Zagazig UniversityCompleted